Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€13.50

€13.50

0.630%
0.085
0.630%
€14.89
 
10:10 / Tradegate WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Hims & Hers Health Inc. Stock

The Hims & Hers Health Inc. stock is trending slightly upwards today, with an increase of €0.085 (0.630%) compared to yesterday's price.
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Hims & Hers Health Inc..
As a result the target price of 14 € shows a slightly positive potential of 3.74% compared to the current price of 13.5 € for Hims & Hers Health Inc..

Pros and Cons of Hims & Hers Health Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Seaport Res Ptn.
Ratings data for HIMS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.77%
Target price 18.548
Change
Ends at 10.04.25

Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 10.61%
Target price 14.774
Change
Ends at 28.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Imperial Capital from an "in-line" rating to an "outperform" rating. They now have a $16.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Show more